AEVA TECHNOLOGIES INC (AEVA)

US00835Q2021 - Common Stock

3.68  -0.05 (-1.34%)

Premarket: 3.7 +0.02 (+0.54%)

Fundamental Rating

3

AEVA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. No worries on liquidiy or solvency for AEVA as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, AEVA is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

AEVA had negative earnings in the past year.
AEVA had a negative operating cash flow in the past year.
In the past 5 years AEVA always reported negative net income.
AEVA had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

AEVA has a Return On Assets of -95.24%. This is amonst the worse of the industry: AEVA underperforms 91.87% of its industry peers.
AEVA has a worse Return On Equity (-124.62%) than 87.80% of its industry peers.
Industry RankSector Rank
ROA -95.24%
ROE -124.62%
ROIC N/A
ROA(3y)-40.19%
ROA(5y)-47.56%
ROE(3y)-44.11%
ROE(5y)-53.53%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AEVA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

AEVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AEVA has been increased compared to 1 year ago.
AEVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

AEVA has an Altman-Z score of -3.86. This is a bad value and indicates that AEVA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -3.86, AEVA is doing worse than 84.55% of the companies in the same industry.
There is no outstanding debt for AEVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -3.86
ROIC/WACCN/A
WACC10.01%

2.3 Liquidity

A Current Ratio of 4.32 indicates that AEVA has no problem at all paying its short term obligations.
The Current ratio of AEVA (4.32) is better than 76.42% of its industry peers.
A Quick Ratio of 4.26 indicates that AEVA has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.26, AEVA belongs to the top of the industry, outperforming 83.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.32
Quick Ratio 4.26

5

3. Growth

3.1 Past

AEVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.51%, which is quite good.
Looking at the last year, AEVA shows a very strong growth in Revenue. The Revenue has grown by 176.22%.
AEVA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.80% yearly.
EPS 1Y (TTM)18.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.67%
Revenue 1Y (TTM)176.22%
Revenue growth 3Y-3.8%
Revenue growth 5YN/A
Sales Q2Q%177.78%

3.2 Future

Based on estimates for the next years, AEVA will show a very strong growth in Earnings Per Share. The EPS will grow by 29.27% on average per year.
Based on estimates for the next years, AEVA will show a very strong growth in Revenue. The Revenue will grow by 200.91% on average per year.
EPS Next Y27.75%
EPS Next 2Y14.35%
EPS Next 3Y8.73%
EPS Next 5Y29.27%
Revenue Next Year107.55%
Revenue Next 2Y108.15%
Revenue Next 3Y140.26%
Revenue Next 5Y200.91%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AEVA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AEVA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.35%
EPS Next 3Y8.73%

0

5. Dividend

5.1 Amount

No dividends for AEVA!.
Industry RankSector Rank
Dividend Yield N/A

AEVA TECHNOLOGIES INC

NYSE:AEVA (11/18/2024, 8:07:27 PM)

Premarket: 3.7 +0.02 (+0.54%)

3.68

-0.05 (-1.34%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap198.28M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -95.24%
ROE -124.62%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.32
Quick Ratio 4.26
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)18.51%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y27.75%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)176.22%
Revenue growth 3Y-3.8%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y